Trident Lifeline Ltd (TLL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Trident Lifeline Ltd on NSE and BSE, with an AI summary of each filing.
With reference to the Financial Result submitted on October 26, 2026 and Revised Financial Results submitted by the Company on October 27, 2026, pursuant to Regulation 30 and Regulation ....
Others (Uncategorized) · 04 Nov 2026, 7:25 pm
Trident Lifeline Details Revisions in H1 FY27 Financial Statements Following BSE Query Trident Lifeline clarified schedule regrouping revisions in its Standalone and Consolidated results for the half-year ended 30th Sep'26 following BSE queries. On a standalone basis, long-term borrowings were revised to INR 2,130.82 lacs (from INR 3,340.36 lacs) and short-term borrowings to INR 2,100.17 lacs (from INR 890.63 lacs). Consolidated long-term debt was adjusted to INR 5,445.20 lacs and short-term debt to INR 3,548.72 lacs. The company confirmed that total balance sheet figures, cash flows, and net profit remained unchanged.
In terms of regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, please find enclosed herewith a copy of Press Release for the Unaudited Financial ....
Press Release · 29 Oct 2026, 7:00 pm
Trident Lifeline Reports Robust Q2 FY27 Results With 50% YoY Revenue Growth Trident Lifeline delivered strong consolidated performance in Q2 FY27, with revenue rising 50% YoY (40% QoQ) to ₹47.1 crore. EBITDA expanded 65% YoY to ₹11.3 crore, with margins expanding 217 bps YoY to 24.1%. PAT grew 30% YoY and QoQ to ₹6.6 crore. Growth was driven by capacity utilization, subsidiary contributions, and market expansion. The company plans to commission its parenterals facility post-Diwali, raise capital via a preferential issue, and targets tripling consolidated business over the next three years.
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed details of voting results inclusive of remote e-voting ....
Extra Ordinary General Meeting · 29 Oct 2026, 6:46 pm
Trident Lifeline Shareholders Approve Preferential Issues and Articles Alteration Trident Lifeline Limited announced the voting results of its EGM held on 27th Oct'26. Shareholders unanimously approved all three special resolutions with 100% votes cast in favor (7,220,880 total votes polled across 60.39% voter turnout). The approved items include altering the company's Articles of Association, issuing equity shares on a preferential basis, and issuing convertible warrants on a preferential basis. Promoter participation stood at 86.84% (6,485,280 shares), while public non-institutional participation reached 17.07% (735,600 shares).
Revised Un-Audited Financial Statement for the Half Year ended 30.09.2026
Others (Uncategorized) · 28 Oct 2026, 2:25 am
Trident Lifeline Reports Robust Consolidated Revenue and Profit Growth in H1'26 Trident Lifeline reported a consolidated revenue from operations of ₹8,080.23 lacs for the half year ended 30th Sep'26, up 62.8% YoY from ₹4,962.17 lacs. Consolidated net profit attributable to shareholders surged 60.1% YoY to ₹1,162.72 lacs versus ₹726.20 lacs in the prior period, with basic EPS rising to ₹9.72 from ₹6.32. On a standalone basis, revenue reached ₹5,956.91 lacs (up 28.8% YoY) and net profit rose 37.8% YoY to ₹1,159.58 lacs. Operating cash flows stood strong at ₹1,154.34 lacs consolidated.
We are resubmitting the Financial Results due to an inadvertent error in the previously filed results dated 26.10.2026. We regret the inconvenience caused and request you to consider the revised ....
Financial Result · 28 Oct 2026, 2:16 am
Trident Lifeline Reports Strong Half-Year and Q2 FY27 Financial Results Trident Lifeline submitted revised unaudited financial results for the period ended 30th Sep'26. For H1 FY27, consolidated revenue from operations reached ₹8,080.23 lakh compared to ₹4,962.17 lakh in H1 FY26, with net profit after minority interest rising to ₹1,162.72 lakh from ₹726.20 lakh YoY. In Q2 FY27, consolidated revenue stood at ₹4,708.40 lakh, generating net profit of ₹659.68 lakh (EPS ₹5.69). On a standalone basis, H1 FY27 revenue rose to ₹5,956.91 lakh and net profit expanded to ₹1,159.58 lakh.
We are resubmitting the Financial Results due to an inadvertent error in the previously filed results dated 26.10.2026. We regret the inconvenience caused and request you to consider the revised ....
Outcome · 28 Oct 2026, 1:58 am
Trident Lifeline Reports Robust Q2 and H1 Growth Trident Lifeline Limited filed revised results showing strong performance for the period ended 30th Sep'26. Consolidated Q2 revenue from operations grew 50.2% YoY to ₹4,708.40 lacs compared to ₹3,133.70 lacs in Q2'25, with net profit after minority interest rising 33.3% YoY to ₹659.68 lacs against ₹494.85 lacs. For H1'26, consolidated revenue from operations surged 62.8% YoY to ₹8,080.23 lacs, driving net profit up 60.1% YoY to ₹1,162.72 lacs. Standalone H1'26 revenue stood at ₹5,956.91 lacs with PAT at ₹1,159.58 lacs.
Further to our letter dated 05th October, 2026 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), ....
Extra Ordinary General Meeting · 27 Oct 2026, 11:50 pm
Trident Lifeline EGM Approves Preferential Issue of Equity and Convertible Warrants Trident Lifeline Limited conducted its Extra-Ordinary General Meeting on 27th Oct'26 to seek shareholder approval for key capital-raising and structural proposals via special resolutions. The agenda included altering the company's Articles of Association, approving the issuance of equity shares on a preferential basis, and issuing convertible share warrants to proposed allottees on a preferential basis. Voting was conducted electronically, with consolidated scrutinizer results and final voting outcomes scheduled for disclosure to stock exchanges within 48 working hours.
Declared a First interim dividend for Financial Year 2026-27
Dividend · 27 Oct 2026, 4:57 am
Trident Lifeline Reports H1 FY27 Results and Declares First Interim Dividend Trident Lifeline approved its unaudited financial results for the half year ended 30th Sep'26 and declared a first interim dividend of Rs. 0.50 per share for FY27, setting the record date as 30th Oct'26. On a consolidated basis, revenue from operations for H1 FY27 rose to Rs. 8,080.23 lacs from Rs. 4,962.17 lacs in H1 FY26, while net profit attributable to shareholders reached Rs. 1,162.72 lacs compared to Rs. 726.20 lacs YoY. Consolidated basic EPS for the half year stood at Rs. 9.72.
The 'Record Date' for determining entitlement of members of the Company for the aforesaid Interim Dividend will be Friday, October 30, 2026
Dividend · 27 Oct 2026, 4:54 am
Trident Lifeline Reports H1 Results and Declares First Interim Dividend Trident Lifeline reported consolidated net sales of ₹8,080.23 lacs for the half year ended 30th Sep'26, up 62.8% YoY from ₹4,962.17 lacs. Total income rose to ₹8,234.36 lacs, while consolidated profit after tax grew 60.1% YoY to ₹1,162.72 lacs from ₹726.20 lacs, translating to an EPS of ₹9.72. On a standalone basis, net profit reached ₹1,159.58 lacs on net sales of ₹5,956.91 lacs. The Board declared a first interim dividend of ₹0.50 per share for FY27, setting the record date as 30th Oct'26.
Declared a First interim dividend for Financial Year 2026-27
Dividend · 27 Oct 2026, 4:51 am
Trident Lifeline Reports H1 FY27 Results and Declares Interim Dividend Trident Lifeline declared a first interim dividend of Rs. 0.50 per share for FY27, setting the record date as 30th Oct'26. For H1 FY27, consolidated revenue from operations rose 62.8% YoY to Rs. 8,080.23 lacs from Rs. 4,962.17 lacs in H1 FY26. Consolidated net profit attributable to shareholders increased 60.1% YoY to Rs. 1,162.72 lacs versus Rs. 726.20 lacs, with basic EPS improving to Rs. 9.72 from Rs. 6.32. On a standalone basis, H1 FY27 PAT grew 37.8% YoY to Rs. 1,159.58 lacs.
The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone and Consolidated Financial Results for the half year ended 30th September, 2026. (The copy of Un-Audited ....
Financial Result · 27 Oct 2026, 4:47 am
Trident Lifeline Reports H1 Results and Declares Interim Dividend Trident Lifeline’s board approved unaudited financial results for the half-year ended 30th Sep'26 and declared a first interim dividend of Rs. 0.50 per share for FY27, setting the record date as 30th Oct'26. On a consolidated basis, revenue from operations for the half-year rose to Rs. 8,080.23 lacs from Rs. 4,962.17 lacs YoY, while net profit after minority interest increased to Rs. 1,162.72 lacs compared to Rs. 726.20 lacs YoY. Consolidated basic EPS for the half-year stood at Rs. 9.72.
Outcome of Board Meeting held on 26.10.2026
Outcome · 27 Oct 2026, 4:41 am
Trident Lifeline Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs) ■ Revenue: 4,708 (+50.3% YoY | +39.6% QoQ) ■ EBITDA: 1,132 (+65.1% YoY | +33.0% QoQ) ■ EBITDA Margin (%): 24.1 (+217 bps YoY | -120 bps QoQ) ■ PAT: 660 (+33.3% YoY | +31.1% QoQ) ■ EPS (INR): 5.69 (+33.3% YoY | +33.3% QoQ)
Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results ....
Intimation · 26 Oct 2026, 5:30 am
Trident Lifeline Board to Consider H1 FY27 Results and Interim Dividend Trident Lifeline Limited has scheduled a Board of Directors meeting on 26th Oct'26 to consider and approve the standalone and consolidated unaudited financial results for the half year ended 30th Sep'26. The board will also evaluate the declaration of a first interim dividend for FY27. Per SEBI insider trading regulations, the trading window for company shares has been closed since 1st Oct'26 and will reopen 48 hours after the public announcement of the board meeting results.
Allotment of 24000 Equity Shares pursuant to conversion of warrants.
Others (Uncategorized) · 17 Oct 2026, 9:01 pm
Trident Lifeline Allots 24,000 Equity Shares Following Warrant Conversion Trident Lifeline Limited’s Board approved the allotment of 24,000 equity shares of face value Rs. 10 each on 17th Oct'26, pursuant to the conversion of an equal number of warrants on a preferential basis. The allotment was made to Vishal Bhupendra Halvawala at an issue price of Rs. 266 per share (Rs. 256 premium) upon receipt of the remaining 75% balance payment of Rs. 47.88 lakh. Following the conversion, the company's paid-up equity share capital increased to Rs. 11.98 crore, comprising 1.198 crore equity shares.
Allotment of 24000 Equity Shares Pursuant to conversion of Warrants.
Others (Uncategorized) · 17 Oct 2026, 8:54 pm
Trident Lifeline Allots 24,000 Equity Shares on Warrant Conversion Trident Lifeline Limited’s Board of Directors approved the allotment of 24,000 equity shares (face value Rs. 10 each) on 17th Oct'26, following the conversion of equal warrants at an issue price of Rs. 266 per share (including Rs. 256 premium). The company received Rs. 47.88 lakh, representing the remaining 75% exercise consideration (Rs. 199.50 per warrant) from warrant holder Vishal Bhupendra Halvawala. Post-allotment, the company's paid-up equity share capital increased to Rs. 11.98 crore, divided into 1,19,81,000 equity shares.
Trident Lifeline Limited has issued corrigendum to the Notice of EOGM
Extra Ordinary General Meeting · 16 Oct 2026, 8:11 pm
Trident Lifeline Issues Corrigendum for ₹57.98 Crore Preferential Issue Trident Lifeline Limited issued a corrigendum to its EGM notice scheduled for 27th Oct'26, updating disclosures following BSE observations and rectifying UBO details for Fincos Technology Solutions. The company seeks approval to raise ₹41.14 crore via 12.22 lakh equity shares to public investors and ₹16.84 crore via 5.00 lakh convertible warrants to promoter and non-promoter groups, both priced at ₹336.60 per share/warrant (relevant date: 25th Sep'26). Proceeds will fund working capital, subsidiary investments, and general corporate purposes over 24 months. Total promoter shareholding will adjust to 56.35% post-issue.
Outcome of Board Meeting held on 16.10.2026
Others (Uncategorized) · 16 Oct 2026, 7:38 pm
Trident Lifeline Approves EGM Corrigendum for Preferential Issue Proceeds Allocation Trident Lifeline's board approved an EGM notice corrigendum on 16th Oct'26 following stock exchange instructions regarding its preferential issue of 12,22,200 equity shares and 5,00,400 warrants. The company detailed object allocations of ₹4,113.93 lacs for the equity issue and ₹1,684.35 lacs for warrants to fund working capital, subsidiary investments, and expansion over 24 months. The board also updated Ultimate Beneficial Owner details for key allottees, including Rushabh Vinay Nisar HUF (1,00,800 shares; 0.71% post-issue) and Fincos Technology Solutions (7,200 shares; 0.05% post-issue).
We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company has made Private Placement of equity shares to other shareholders. ....
Others (Uncategorized) · 15 Oct 2026, 11:34 pm
Trident Lifeline Dilutes Stake in Subsidiary Trident Mediquip to 58.23% Trident Lifeline Limited announced that its subsidiary, Trident Mediquip Limited (TML), completed a private placement of equity shares to other shareholders. Following the allotment, Trident Lifeline's stake in TML diluted from 59.67% to 58.23%. TML operates in the medical device industry with a paid-up capital of Rs 10.25 cr and reported a turnover of Rs 27.31 cr in FY25-26, up from Rs 21.29 cr in FY24-25 and Rs 20.58 cr in FY23-24.
Please find enclosed Press Release titled 'CPHI Milan 2026: Opening doors to regulated markets and new global business opportunities' issued on October 09, 2026.
Press Release · 09 Oct 2026, 11:17 pm
Trident Lifeline Expands Global Regulated Market Reach via CPHI Milan 2026 Trident Lifeline participated in CPHI Milan 2026 from 6th Oct'26 to 8th Oct'26 at Fiera Milano, Italy, aiming to accelerate entry into high-bar regulated pharmaceutical markets. The company showcased its diversified finished-dose portfolio—covering pharmaceuticals, nutraceuticals, injectables, and medical devices—to global stakeholders. Participation provided high-volume organic leads, access to niche international buyers outside initial projections, and ground-level market intelligence to align its hybrid manufacturing model and regulatory compliance strategies with shifting global pharma demand.
This is in continuation of the Outcome of the Board Meeting submitted by the Company to the Exchange on October 05, 2026 regarding the Board Meeting held on October 5, 2026 pursuant to ....
Outcome · 06 Oct 2026, 10:38 pm
Trident Lifeline Clarifies Typographical Errors in Board Meeting Outcome Trident Lifeline Limited has issued a clarification regarding inadvertent typographical and clerical errors in Annexure-I of its board meeting outcome dated 5th Oct'26. The revisions correct three specific names: Serial Number 3 is revised from "Amit Mehta" to "Amit Gunchandra Mehta", Serial Number 8 from "Santosh Kumar Shah" to "SKS HUF", and Serial Number 13 from "Ramcharan Lath" to "Ramchandra Lath". The company confirmed that all other terms, information, and board approvals from the original disclosure remain entirely unchanged.
We would like to inform you that the Extra-Ordinary General Meeting is scheduled to be held on Tuesday, October 27, 2026, at 04.00 p.m.(IST) through Video Conferencing ("VC") or Other Audio ....
Extra Ordinary General Meeting · 05 Oct 2026, 11:43 pm
Trident Lifeline Plans Rs 57.98 Crore Preferential Issue Across Equity And Warrants Trident Lifeline Limited has convened an EGM on 27th Oct'26 to seek approval for raising up to Rs 57.98 crore via preferential allotments at an issue price of Rs 336.60 per security (face value Rs 10, premium Rs 326.60). The fundraise comprises issuing up to 12,22,200 equity shares to non-promoter public investors aggregating Rs 41.14 crore, and 5,00,400 convertible warrants aggregating Rs 16.84 crore to promoter and non-promoter groups. Proceeds will fund working capital, subsidiary investments, debt repayment, and business expansion.
The Board of Director has approved the alteration of Article of Association, subject to the approval of Members
Others (Uncategorized) · 05 Oct 2026, 7:18 pm
Trident Lifeline Approves Rs 57.98 Crore Preferential Issue of Shares and Warrants Trident Lifeline's board approved raising up to Rs 57.98 crore via preferential allotment at Rs 336.60 per security on 5th Oct'26. The issue comprises 12,22,200 equity shares worth Rs 41.14 crore to non-promoter public investors and 5,00,400 fully convertible warrants worth Rs 16.84 crore to promoter and public categories, exercisable within 18 months. Following the issue and full conversion, promoter shareholding will decrease from 62.46% to 56.35%, while public holding rises to 43.65%, subject to shareholder approval at an EGM on 27th Oct'26.
Trident Lifeline Limited has announced the issue of Equity shares and Warrants on preferential basis.
Others (Uncategorized) · 05 Oct 2026, 7:15 pm
Trident Lifeline Approves Preferential Issue Worth ₹57.98 Crore Trident Lifeline's board approved a preferential issue to raise up to ₹57.98 crore at ₹336.60 per security on 5th Oct'26. The fundraise comprises 12,22,200 equity shares worth ₹41.14 crore to non-promoter public investors and up to 5,00,400 fully convertible warrants worth ₹16.84 crore to promoters and non-promoters, exercisable within 18 months. Following full conversion, promoter shareholding will dilute from 62.46% to 56.35%, while public shareholding will rise from 37.54% to 43.65%. An EGM is scheduled on 27th Oct'26 to seek shareholder approval.
Outcome of Board Meeting held on 05.10.2026
Outcome · 05 Oct 2026, 7:11 pm
Trident Lifeline Approves Rs. 57.98 Crore Preferential Issue of Shares and Warrants Trident Lifeline's board approved a preferential issue to raise up to Rs. 57.98 crore on 5th Oct'26 at an issue price of Rs. 336.60 per security (face value Rs. 10). The issue comprises 12,22,200 equity shares aggregating Rs. 41.14 crore to non-promoter public investors and up to 5,00,400 fully convertible warrants aggregating Rs. 16.84 crore to promoter and public categories, exercisable within 18 months. Post-allotment on a fully diluted basis, promoter shareholding will decrease from 62.46% to 56.35%, while public shareholding will rise to 43.65%.
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that the Company ....
Intimation · 03 Oct 2026, 6:25 pm
Trident Lifeline Schedules Virtual Investor Meeting with Lucky Investments Trident Lifeline Limited announced a virtual institutional investor meeting scheduled for 3rd Oct'26 from 2:00 PM to 3:00 PM with Lucky Investments, arranged by Neo Atlas Capital Advisory LLP. The interaction will rely exclusively on publicly available information, with no unpublished price-sensitive information being discussed.